| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |